Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2012-09-13 11:47:09 UTC |
---|
Update Date | 2021-09-14 15:45:32 UTC |
---|
HMDB ID | HMDB0041905 |
---|
Secondary Accession Numbers | - HMDB0060598
- HMDB0060972
- HMDB41905
- HMDB60598
- HMDB60972
|
---|
Metabolite Identification |
---|
Common Name | 4-Hydroxyphenytoin |
---|
Description | 4-Hydroxyphenytoin, also known as 4'-HPPH, belongs to the class of organic compounds known as phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. In humans, 4-hydroxyphenytoin is involved in the metabolic disorder called the phenytoin (antiarrhythmic) action pathway. 4-Hydroxyphenytoin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 4-Hydroxyphenytoin. |
---|
Structure | OC1=NC(C(O)=N1)(C1=CC=CC=C1)C1=CC=C(O)C=C1 InChI=1S/C15H12N2O3/c18-12-8-6-11(7-9-12)15(10-4-2-1-3-5-10)13(19)16-14(20)17-15/h1-9,18H,(H2,16,17,19,20) |
---|
Synonyms | Value | Source |
---|
(Hydroxyphenyl)phenylhydantoin | ChEBI | (p-Hydroxyphenyl)phenylhydantoin | ChEBI | 4-Hydroxydiphenylhydantoin | ChEBI | 5-(4'-Hydroxyphenyl)-5-phenylhydantoin | ChEBI | 5-(p-Hydroxyphenyl)-5-phenylhydantoin | ChEBI | Hydroxydiphenylhydantoin | ChEBI | Hydroxyphenytoin | ChEBI | p-Hydroxydiphenylhydantoin | ChEBI | p-Hydroxyphenytoin | ChEBI | Para-hydroxyphenytoin | ChEBI | 5-(4-Hydroxyphenyl)-5-phenyl-2,4-imidazolidinedione | HMDB | 5-(4-Hydroxyphenyl)-5-phenylhydantoin | HMDB | 5-(p-Hydroxyphenyl)-5-phenyl-hydantoin | HMDB | Hydroxyphenytoin, (R)-isomer | HMDB | 4'-HPPH | HMDB | 4-HPPH | HMDB | Hydroxyphenytoin, (+-)-isomer | HMDB | Hydroxyphenytoin, (S)-isomer | HMDB | Hydroxyphenytoin, 11C-labeled | HMDB |
|
---|
Chemical Formula | C15H12N2O3 |
---|
Average Molecular Weight | 268.2674 |
---|
Monoisotopic Molecular Weight | 268.08479226 |
---|
IUPAC Name | 4-(4-hydroxyphenyl)-4-phenyl-4H-imidazole-2,5-diol |
---|
Traditional Name | 5-(4-hydroxyphenyl)-5-phenylimidazole-2,4-diol |
---|
CAS Registry Number | 2784-27-2 |
---|
SMILES | OC1=NC(C(O)=N1)(C1=CC=CC=C1)C1=CC=C(O)C=C1 |
---|
InChI Identifier | InChI=1S/C15H12N2O3/c18-12-8-6-11(7-9-12)15(10-4-2-1-3-5-10)13(19)16-14(20)17-15/h1-9,18H,(H2,16,17,19,20) |
---|
InChI Key | XEEDURHPFVXALT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azolidines |
---|
Sub Class | Imidazolidines |
---|
Direct Parent | Phenylhydantoins |
---|
Alternative Parents | |
---|
Substituents | - Diphenylmethane
- 5-phenylhydantoin
- Phenylimidazolidine
- Alpha-amino acid or derivatives
- 5-monosubstituted hydantoin
- 1-hydroxy-2-unsubstituted benzenoid
- N-acyl urea
- Phenol
- Ureide
- Monocyclic benzene moiety
- Benzenoid
- Dicarboximide
- Urea
- Carbonic acid derivative
- Carboxylic acid derivative
- Azacycle
- Carbonyl group
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 1.70 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-Hydroxyphenytoin,1TMS,isomer #1 | C[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1 | 2498.1 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,1TMS,isomer #2 | C[Si](C)(C)OC1=NC(O)=NC1(C1=CC=CC=C1)C1=CC=C(O)C=C1 | 2492.7 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,1TMS,isomer #3 | C[Si](C)(C)OC1=CC=C(C2(C3=CC=CC=C3)N=C(O)N=C2O)C=C1 | 2558.6 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TMS,isomer #1 | C[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O[Si](C)(C)C)C=C2)C(O)=N1 | 2505.3 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TMS,isomer #2 | C[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O[Si](C)(C)C)=N1 | 2448.5 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TMS,isomer #3 | C[Si](C)(C)OC1=NC(O)=NC1(C1=CC=CC=C1)C1=CC=C(O[Si](C)(C)C)C=C1 | 2502.8 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,3TMS,isomer #1 | C[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O[Si](C)(C)C)C=C2)C(O[Si](C)(C)C)=N1 | 2540.9 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1 | 2722.2 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=NC(O)=NC1(C1=CC=CC=C1)C1=CC=C(O)C=C1 | 2717.9 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C(C2(C3=CC=CC=C3)N=C(O)N=C2O)C=C1 | 2795.1 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(O)=N1 | 2926.0 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O[Si](C)(C)C(C)(C)C)=N1 | 2851.6 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=NC(O)=NC1(C1=CC=CC=C1)C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1 | 2922.8 | Semi standard non polar | 33892256 | 4-Hydroxyphenytoin,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=NC(C2=CC=CC=C2)(C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(O[Si](C)(C)C(C)(C)C)=N1 | 3072.4 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxyphenytoin GC-MS (Non-derivatized) - 70eV, Positive | splash10-005c-2970000000-f2362aeb837caff92396 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxyphenytoin GC-MS (3 TMS) - 70eV, Positive | splash10-01b9-5026900000-a7352e0820321c5e2123 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxyphenytoin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 10V, Positive-QTOF | splash10-014i-0290000000-2299e419930e3a97862c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 20V, Positive-QTOF | splash10-00kb-0960000000-45490c2de987f0b93b2d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 40V, Positive-QTOF | splash10-0gi1-1900000000-31738f367353e34a82bf | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 10V, Negative-QTOF | splash10-014i-2090000000-e526de0cd9ea6ea5c67b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 20V, Negative-QTOF | splash10-0006-9010000000-61cd151f31d096cf0b46 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 40V, Negative-QTOF | splash10-0006-9300000000-8a074704ab6b4e05587e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 10V, Positive-QTOF | splash10-014i-0090000000-36fb012770300fb47b89 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 20V, Positive-QTOF | splash10-001i-0910000000-81a35adeb459b9224a95 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 40V, Positive-QTOF | splash10-001i-1900000000-a813694dc7e1cf8740c1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 10V, Negative-QTOF | splash10-014i-0090000000-bd7cd943428e7be367e7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 20V, Negative-QTOF | splash10-0006-9330000000-2c2090cefb411296eb0b | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxyphenytoin 40V, Negative-QTOF | splash10-0006-9500000000-16f823d8b48ce7469f21 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
General References | - Jurgens U: Routine determination of hydroxyphenytoin in urine by high-performance liquid chromatography using an automatic column-switching technique. J Chromatogr. 1983 Jul 8;275(2):335-43. [PubMed:6619238 ]
- Sato A, Shimada K, Izumo Y, Sakaguchi T: High-performance liquid chromatographic determination of phenytoin and hydroxyphenytoin in human urine. J Chromatogr. 1983 Jun 10;275(1):97-105. [PubMed:6874875 ]
- Zeng J, Liu D, Zou Y: [High performance liquid chromatographic determination of hydroxyphenytoin in human urine]. Hua Xi Yi Ke Da Xue Xue Bao. 1992 Sep;23(3):321-4. [PubMed:1298726 ]
- Shimada K, Wakabayashi H, Sato A: Gas chromatographic determination of m- and p-hydroxyphenytoin in the urine of epileptic patients. J Chromatogr. 1985 May 3;339(2):331-7. [PubMed:4008572 ]
- Chou RC, Levy G: Effect of pregnancy on the pharmacokinetics of phenytoin in rats. J Pharmacol Exp Ther. 1984 May;229(2):351-8. [PubMed:6716263 ]
- Rambeck B, May T: Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapy. Ther Drug Monit. 1984;6(2):164-72. [PubMed:6740735 ]
- Horsmans Y, Van den Berge V, Bouckaert A, Desager JP: Phenytoin hydroxylation in a healthy Caucasian population: bimodal distribution of hydroxyphenytoin urinary excretion. Pharmacol Toxicol. 1997 Dec;81(6):276-9. [PubMed:9444669 ]
- Yamanaka H, Nakajima M, Hara Y, Katoh M, Tachibana O, Yamashita J, Yokoi T: Urinary excretion of phenytoin metabolites, 5-(4'-hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases. Drug Metab Pharmacokinet. 2005 Apr;20(2):135-43. [PubMed:15855726 ]
|
---|